Skip to main content
OpenTrials
Completed

NCT Number: NCT04086524

A Patch Free Treatment for Young Children With Amblyopia

The purpose of this study is to test whether a binocular treatment can improve vision and motor function in young children with amblyopia. The proposed treatment is an animation series that has been modified so that different characters in the animation are presented to each eye. The contrast of the images shown to the amblyopic eye is higher than the contrast of the images shown to the fellow eye. The aim of the treatment is to promote co-operation between the two eyes and improve visual and motor outcomes. We will compare the benefits of this binocular treatment to patching, whereby the better eye is occluded with an eye patch for two hours per day to force the usage of the weaker eye. We hypothesize that the binocular treatment will improve vision and motor outcomes in young children with amblyopia, and that these improvements will be superior to any effects of patching.

Completed

Looking for future studies?

Notify Me

Key information

Age range

36 month–83 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Queensland University of Technology, Brisbane, Queesnland, Australia

Loading trial locations.

About this study

This is a prospective study with study sites in Ontario, Canada (University of Waterloo); Quebec, Canada (University of McGill); Texas, United States of America (Retina Foundation of the Southwest); and Queensland, Australia (Queensland University of Technology). There are three study conditions. 1) binocular treatment at home, 2) binocular treatment in office and, 3) standard patching therapy.

Participants will be recruited from university-affiliated clinics and local clinical practices. Following full informed consent, participants will complete baseline testing to confirm eligibility and provide pre-treatment measurements of visual acuity, stereopsis, interocular suppression and motor function. Eligible participants will then be randomized to either binocular treatment or patching.

The treatment consists of dichoptically presented children's animations with all characters seen by the amblyopic eye and only a subset of characters seen by the fellow eye. Images shown to the amblyopic eye will be presented at 100% contrast and images presented to the fellow eye will be presented at 20% contrast on session 1 and contrast will increment by 10% of the prior session's contrast level for each subsequent session. Participants will complete 4 x 1-hour sessions per week for two weeks. After 2 weeks of treatment, participants will be offered the opportunity to complete an additional 2 weeks (8 hours) of treatment. Treatment will take place in the home or in-office depending on the study site.

The control group will patch for 2 hours every day, at home, for 2 weeks. A calendar will be provided (to both groups) in order for parents to track compliance. After 2 weeks of patching, participants in the control group have the option to crossover to the treatment group for an additional 2 weeks.

The primary analysis will compare visual acuity improvements from baseline between the binocular treatment and patching groups after 2 weeks of treatment. Secondary analyses will include comparisons of binocular vision and motor function outcomes between the binocular treatment and patching groups, comparisons of at-home vs. in-office binocular treatment outcomes and an evaluation of crossover effects.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 3-5.9 years old (36-83 months at the time of registration)
  • Confirmed diagnosis of amblyopia
  • Best-corrected visual acuity of 20/32 - 20/100 in the amblyopic eye
  • Best-corrected visual acuity of 20/16 - 20/40 in fellow eye for ages 3-4, and 20/16-20/32 for ages 5-5.9
  • Interocular difference in visual acuity of 3 lines or greater
  • If anisometropic, anisometropia (≥1.00D)
  • Wearing glasses for 8+ weeks + no change in VA w/ glasses for 4-6 weeks
  • Must be able to experience simultaneous perception when viewing the binocular treatment stimuli with an appropriate interocular contrast offset
  • Doctor and parent must be willing to forego patching/drops for 4 week study period

Exclusion criteria

  • strabismus
  • Diagnosed eye disease or visual disorder other than amblyopia or anisometropia
  • >8 weeks premature
  • Diagnosed or suspected developmental delay (eg. learning disability, autism, Down syndrome)
  • Diagnosed systemic disease (eg. diabetes, lupus, albinism)

Treatment and study plan

Binocular cartoon treatment at home

Other

see arm description.

Patching

Other

see arm description

Other names: occlusion therapy, penalization

Binocular cartoon treatment in office

Other

see arm description.

Primary outcomes

  1. Visual acuity

    Time frame: 2 weeks

    Change in visual acuity, measured in logMAR using an electronic HOTV test

Secondary outcomes

  1. Visual acuity

    Time frame: 4 weeks

    Change in visual acuity, measured in logMAR an electronic HOTV test

  2. Motor function

    Time frame: 2 weeks

    Change in motor function, measured using the Movement Assessment Battery for Children-2 (version 2)

  3. Stereopsis

    Time frame: 2 weeks

    Change in stereopsis, measured using the Randot Preschool Stereoacuity Test

  4. Treatment adherence

    Time frame: 4 weeks

    Self-reported amount of time spent viewing the cartoon or patching compared to amount of prescribed time

  5. Treatment adherence

    Time frame: 2 weeks

    Self-reported amount of time spent viewing the cartoon or patching compared to amount of prescribed time

  6. Stereopsis

    Time frame: 4 weeks

    Change in stereopsis, measured using the Randot Preschool Stereoacuity Test

  7. Motor function

    Time frame: 4 weeks

    Change in motor function, measured using the Movement Assessment Battery for Children-2 (version 2)

  8. Interocular suppression

    Time frame: 2 weeks

    Change in interocular suppression measured using the Worth 4 dot test

  9. Interocular suppression

    Time frame: 4 weeks

    Change in interocular suppression measured using the Worth 4 dot test

  10. Interocular contrast balance

    Time frame: 2 weeks

    Change in interocular contrast balance measured using a dichoptic letter chart

  11. Interocular contrast balance

    Time frame: 4 weeks

    Change in interocular contrast balance measured using a dichoptic letter chart

Sponsors and collaborators

Lead sponsor

University of Waterloo

Other

Collaborators

  • McGill University
  • Queensland University of Technology
  • Retina Foundation of the Southwest

Registry information

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Sep 11, 2019
Registry last updated
Mar 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.